Literature DB >> 27551923

Obesity and anthropometry in spina bifida: What is the best measure.

Joceline S Liu1, Caroline Dong1, Amanda X Vo1, Laura Jo Dickmeyer1, Claudia L Leung1, Richard A Huang2, Stephanie J Kielb1, Shubhra Mukherjee3.   

Abstract

OBJECTIVE: Diagnosis of obesity using traditional body mass index (BMI) using length may not be a reliable indicator of body composition in spina bifida (SB). We examine traditional and surrogate measures of adiposity in adults with SB, correlated with activity, metabolic disease, attitudes towards exercise and quality of life.
DESIGN: Adult subjects with SB underwent obesity classification using BMI by length and arm span, abdominal girth and percent trunk fat (TF) on dual energy X-ray absorptiometry (DXA). Quality of life measures, activity level and metabolic laboratory values were also reviewed.
RESULTS: Among eighteen subjects (6 male, 12 female), median age was 26.5 (range 19-37) years, with level of lesion 16.7% ≤L2, 61.1% L3-4, and 22.2% ≥L5, respectively. Median weight was 71.8 (IQR 62.4, 85.8) kg, similar between sexes (P = 0.66). With median length of 152.0 (IQR 141.8, 163.3) cm, median conventional BMI was 29.4 m/kg2, with 7 (43.8%) subjects with BMI >30. Median BMI by arm span was 30.2 m/kg2, abdominal girth of 105.5 cm, and TF 45.7%. More subjects were classified as obese using alternate measures, with 9 (56.3%) by arm span, 14 (82.4%) by abdominal girth and 15 (83.3%) by TF (P = 0.008). Reclassification of obesity from conventional BMI was significant when using TF (P = 0.03). No difference in quality of life measures, activity level and metabolic abnormalities was demonstrated between obese and non-obese subjects.
CONCLUSIONS: Conventional determination of obesity using BMI by length is an insensitive marker in adults with SB. Adults with SB are more often classified as obese using TF by DXA.

Entities:  

Keywords:  Anthropometric measures; Body fat; Body mass index; Obesity; Spina bifida

Mesh:

Year:  2016        PMID: 27551923      PMCID: PMC5810807          DOI: 10.1080/10790268.2016.1195071

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  44 in total

1.  The Satisfaction With Life Scale.

Authors:  E Diener; R A Emmons; R J Larsen; S Griffin
Journal:  J Pers Assess       Date:  1985-02

2.  Physical activity among adults with a disability--United States, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-10-05       Impact factor: 17.586

3.  Coronary artery disease: metabolic risk factors and latent disease in individuals with paraplegia.

Authors:  W A Bauman; A M Spungen; M Raza; J Rothstein; R L Zhang; Y G Zhong; M Tsuruta; R Shahidi; R N Pierson; J Wang
Journal:  Mt Sinai J Med       Date:  1992-03

4.  Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality.

Authors:  Kathryn A Britton; Joseph M Massaro; Joanne M Murabito; Bernard E Kreger; Udo Hoffmann; Caroline S Fox
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

Review 5.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

Review 6.  A review of body mass index and waist circumference as markers of obesity and coronary heart disease risk in persons with chronic spinal cord injury.

Authors:  A C Buchholz; J M Bugaresti
Journal:  Spinal Cord       Date:  2005-09       Impact factor: 2.772

7.  State-specific prevalence of obesity among adults with disabilities--eight states and the District of Columbia, 1998-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-09-13       Impact factor: 17.586

8.  Cardiovascular disease risk factors and the relationships with physical activity, aerobic fitness, and body fat in adolescents and young adults with myelomeningocele.

Authors:  Laurien M Buffart; Rita J van den Berg-Emons; Alex Burdorf; Wim G Janssen; Henk J Stam; Marij E Roebroeck
Journal:  Arch Phys Med Rehabil       Date:  2008-10-02       Impact factor: 3.966

9.  Neurogenic faecal incontinence in children with spina bifida: rectosphincteric responses and evaluation of a physiological rationale for management, including biofeedback conditioning.

Authors:  K Shepherd; R Hickstein; R Shepherd
Journal:  Aust Paediatr J       Date:  1983-06

Review 10.  Body composition in adolescents: measurements and metabolic aspects.

Authors:  G Rodríguez; L A Moreno; M G Blay; V A Blay; J M Garagorri; A Sarría; M Bueno
Journal:  Int J Obes Relat Metab Disord       Date:  2004-11
View more
  6 in total

Review 1.  Obesity Prevention for Individuals with Spina Bifida.

Authors:  Michele Polfuss; Linda G Bandini; Kathleen J Sawin
Journal:  Curr Obes Rep       Date:  2017-06

2.  Health behaviors and disordered eating in adolescents and young adults with spina bifida: results from a national survey.

Authors:  Colleen Stiles-Shields; Grayson N Holmbeck
Journal:  Disabil Rehabil       Date:  2019-04-12       Impact factor: 3.033

Review 3.  Care for Adults with Spina Bifida: Current State and Future Directions.

Authors:  Shubhra Mukherjee; Jacqueline Pasulka
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017

Review 4.  Metabolic Syndrome in Children With Myelomeningocele and the Role of Physical Activity: A Narrative Review of the Literature.

Authors:  Gabrielle Gour-Provençal; Camille Costa
Journal:  Top Spinal Cord Inj Rehabil       Date:  2022-08-17

5.  Fat-Bone Interactions in Adults With Spina Bifida.

Authors:  Anne Trinh; Phillip Wong; Anuradha Sakthivel; Michael C Fahey; Sabine Hennel; Justin Brown; Boyd J Strauss; Peter R Ebeling; Peter J Fuller; Frances Milat
Journal:  J Endocr Soc       Date:  2017-09-27

6.  Adults with spina bifida: A cross-sectional study of health issues and living conditions.

Authors:  Martina Bendt; Hanna Gabrielsson; Dorothee Riedel; Göran Hagman; Claes Hultling; Erika Franzén; Mats Eriksson; Åke Seiger
Journal:  Brain Behav       Date:  2020-07-07       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.